GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-417 Cr | ₹-433 Cr | ₹-799 Cr | ₹15 Cr | ₹35 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-417 Cr |
| Mar2025 | ₹-433 Cr |
| Mar2024 | ₹-799 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹35 Cr |
How is Cash Flow from Financing Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-417 Cr | Negative | |
| Mar2025 | ₹-433 Cr | Negative | |
| Mar2024 | ₹-799 Cr | Negative | |
| Mar2023 | ₹15 Cr | -57.25 | |
| Mar2022 | ₹35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹54,573.8 Cr | 3.6% | 5.9% | 73.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.6% |
5.9% |
73.9% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses